ATX 3.30% 8.8¢ amplia therapeutics limited

Ann: Investor Update - February 2021, page-5

  1. 300 Posts.
    lightbulb Created with Sketch. 72
    this is great! their presentations are some of the most professional ive seen from small cap biotechs.
    I hope we are invited to participate in any potential cap raises,
    looking like completion if phase I and potentially starting two phase II trials - all this year!
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.